The landscape for neurological care is undergoing a massive shift as the global burden of neurodegenerative conditions increases. Central to this evolution is the Parkinson’s Disease Drug Market size, which is witnessing sustained momentum due to demographic changes, technological innovation in drug delivery, and a heightened focus on managing both motor and non-motor symptoms....